title: Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitis.
abstract: Oral tolerance induction with peptide B27PD had an ameliorating effect in uveitis patients, which was also observed in the five-year follow-up period. Repeated treatments with peptide B27PD were also effective. Side effects did not occur in this patient group, not even in patients receiving peptide for up to 42 weeks.
authors.affiliation: Section of Immunobiology, Department of Ophthalmology, Ludwig-Maximilians-University, Mathildenstr. 8, 80336 Munich, Germany. Stephan.Thurau@med.uni-muenchen.de
authors.forename: Stephan R
authors.initials: SR
authors.lastname: Thurau
authors.forename: Harald
authors.initials: H
authors.lastname: Fricke
authors.forename: Christian
authors.initials: C
authors.lastname: Burchardi
authors.forename: Maria
authors.initials: M
authors.lastname: Diedrichs-Möhring
authors.forename: Gerhild
authors.initials: G
authors.lastname: Wildner
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000595:Amino Acid Sequence; D005500:Follow-Up Studies; D015796:HLA-B27 Antigen / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D018928:Immunity, Mucosal; D010446:Peptide Fragments / Q000276:immunology* / Q000627:therapeutic use; D013997:Time Factors; D014605:Uveitis / Q000276:immunology* / Q000628:therapy; D014792:Visual Acuity / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D015796:HLA-B27 Antigen; D010446:Peptide Fragments